Physician

Emily Sarah Charlson, MD

According to 2025 Medicare claims, Emily Charlson, MD (NPI: 1609296466) practices ophthalmology in the San Francisco-San Mateo-Redwood City, CA market, with the plurality of this provider's patient population coming from San Francisco, CA. This provider's primary affiliated billing organization is PACIFIC EYE ASSOCIATES, A MEDICAL CORPORATION (NPI: 1265464739; TIN: 943228329) and primary practice location at 94115-2375.

Charlson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 796 traditional Medicare patients, billed 2,285 HCPCS/CPT codes, and received $285,226 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 957 prescription claims across 556 beneficiaries totaling $133,748 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 89 records totaling $48,961. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,463 to $285,226. Similarly, Part D prescription costs have moved sharply higher in recent years, from $4,258 to $133,748. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$205K$410K2018 Medicare payment: $5,463 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $23,306 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $155,868 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $410,041 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $382,962 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $299,471 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $285,226 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20186883$5,463
2019214305$23,306
20203871,348$155,868
20217952,616$410,041
20228952,681$382,962
20237972,147$299,471
20247962,285$285,226

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$553K$1.1M2016 Drug cost: $4,258 (USD; Tot_Drug_Cst)2017 Drug cost: $8,504 (USD; Tot_Drug_Cst)2018 Drug cost: $10,137 (USD; Tot_Drug_Cst)2019 Drug cost: $9,250 (USD; Tot_Drug_Cst)2020 Drug cost: $21,216 (USD; Tot_Drug_Cst)2021 Drug cost: $185,488 (USD; Tot_Drug_Cst)2022 Drug cost: $1,105,591 (USD; Tot_Drug_Cst)2023 Drug cost: $281,299 (USD; Tot_Drug_Cst)2024 Drug cost: $133,748 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20162047$4,258
201771153$8,504
2018122273$10,137
2019158346$9,250
2020261530$21,216
20214931,037$185,488
20226041,134$1,105,591
20235361,074$281,299
2024556957$133,748

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more179179$118
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more601828$96
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more246286$70
92082Exam of visual field with intermediate testing116120$38
92134Imaging of retina171182$32

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XiidraLifitegrast361,590$34,748
MieboPerfluorohexyloctane/Pf361,080$26,675
RestasisCyclosporine14450$9,230
Alphagan PBrimonidine Tartrate14483$5,351
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha4774,725$4,021

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.89$48,961Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Emily Sarah Charlson, MD?

Tedicare shows public-source Medicare data for Emily Sarah Charlson, MD (NPI 1609296466), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Emily Sarah Charlson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Emily Sarah Charlson, MD?

Emily Sarah Charlson, MD is linked to PACIFIC EYE ASSOCIATES, A MEDICAL CORPORATION (billing NPI 1265464739) in the available physician profile data.

Does Emily Sarah Charlson, MD have Open Payments data?

Emily Sarah Charlson, MD has 89 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.